Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)

Phase 2

• Conditions: Malignancy; Allogeneic Stem Cell Transplantation

• Registration Number: NCT00215007
• Lead Sponsor: Charite University, Berlin, Germany

Brief Summary

The purpose of this study is to evaluate the efficacy of levofloxacin to prevent bacterial infections in the postneutropenic period in patients who have undergone allogeneic stem cell transplantation (SCT).

Detailed Description

Not available

Study Timeline

• Status Verified: 2004-02
• Study First Submitted: 2005-09-15
• Study First Submitted QC: 2005-09-15
• Study First Posted: 2005-09-22
• Last Update Submitted: 2007-11-29
• Last Update Posted: 2007-11-30

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Allogeneic SCT
• Postneutropenic period
• Written consent

Exclusion Criteria

• Fever
• Antibiotic therapy
• Neutropenia
• Refusal by the patient

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Trial Locations

Locations (1)

Charite, CBF; 🇩🇪 Berlin, Germany